Margaritaville at Sea Cruise Line announces a partnership with multi-platinum selling, three-time GRAMMY award-winning, and ...
Initial results of a Phase 1 / 2 open label study of AT-02, the company’s lead pan-amyloid removal therapeutic candidate, in patients with AL amyloidosis will be presented at ASH.The presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results